BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32280695)

  • 21. A prognosis-related based method for miRNA selection on liver hepatocellular carcinoma prediction.
    Liang G; Wu J; Xu L
    Comput Biol Chem; 2021 Apr; 91():107433. PubMed ID: 33540232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma.
    Deng Z; Wang J; Xu B; Jin Z; Wu G; Zeng J; Peng M; Guo Y; Wen Z
    Biomed Res Int; 2019; 2019():2408348. PubMed ID: 31828095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Key Transcription Factors AP-1 and AP-1-Dependent miRNAs Forming a Co-Regulatory Network Controlling PTEN in Liver Ischemia/Reperfusion Injury.
    Zhong Y; Zhu Y; Dong J; Zhou W; Xiong C; Xue M; Shi M; Chen H
    Biomed Res Int; 2019; 2019():8962682. PubMed ID: 31781649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic relevance of miR-137 and its liver microenvironment regulatory target gene AFM in hepatocellular carcinoma.
    Wei Q; Zhao L; Jiang L; Bi J; Yu Z; Zhao L; Song X; Sun M; Chen Y; Wei M
    J Cell Physiol; 2019 Jul; 234(7):11888-11899. PubMed ID: 30523640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microarray‑based bioinformatics analysis of the prospective target gene network of key miRNAs influenced by long non‑coding RNA PVT1 in HCC.
    Zhang Y; Mo WJ; Wang X; Zhang TT; Qin Y; Wang HL; Chen G; Wei DM; Dang YW
    Oncol Rep; 2018 Jul; 40(1):226-240. PubMed ID: 29749550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple-Scales Integrative Analysis of MicroRNAs Unveils Biomarkers and Key Regulatory Connections for Hepatocellular Carcinoma.
    Qian K; Li Q; Deng W; Xiang X
    Crit Rev Eukaryot Gene Expr; 2019; 29(3):189-241. PubMed ID: 31679233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
    Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
    BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling.
    Hsu SD; Huang HY; Chou CH; Sun YM; Hsu MT; Tsou AP
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S12. PubMed ID: 25707768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A microRNA expression profile for vascular invasion can predict overall survival in hepatocellular carcinoma.
    Lin Z; Cai YJ; Chen RC; Chen BC; Zhao L; Xu SH; Wang XD; Song M; Wu JM; Wang YQ; Zhou MT; Shi KQ
    Clin Chim Acta; 2017 Jun; 469():171-179. PubMed ID: 28365450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
    Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
    Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Hepatocellular Carcinoma by Integrated Microarray Analysis.
    Lin X; Chen Y
    Med Sci Monit Basic Res; 2018 Apr; 24():70-78. PubMed ID: 29706616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
    Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
    BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data.
    Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S
    Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis of pseudogene RP11-564D11.3 expression and its potential roles in hepatocellular carcinoma.
    Song H; Yang J; Zhang Y; Zhou J; Li Y; Hao X
    Epigenomics; 2019 Feb; 11(3):267-280. PubMed ID: 30362374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma.
    Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL
    Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma.
    Yang B; Li M; Tang W; Liu W; Zhang S; Chen L; Xia J
    Nat Commun; 2018 Feb; 9(1):678. PubMed ID: 29445139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
    Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
    Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.